Shaping Public Perception of Drones

 

It feels safe to say that virtually every industry has been affected by the pandemic in one way or another. For restaurants and spas, the effects have been devastating. For big players in the e-commerce and digital content space, there has been room for growth. One industry in particular that is stepping in to solve COVID-19 related problems, is the drone industry. This is because drones come in handy when you need to transfer goods without requiring close human interaction. Social distancing can be made more possible with drone technology.

According to Miriam McNabb, CEO at JobForDrones and Contributing Editor at DRONELIFE, drones are stepping in when humans really need to step away for their health and safety. She explained that drone technology has really allowed certain workspaces, such as industrial sites and mining sites, to keep functioning with fewer people on the ground and more distance between them.

Contactless delivery is another prime example of how drones can make life easier during the pandemic. “If you’re telling people to quarantine, you have to have a way to get them the food and supplies that they need. If you don’t want someone to go into a grocery store, when they have COVID-19, you’ve got to provide them with an alternative and you don’t necessarily want to put delivery people at risk,” McNabb said. Contactless delivery methods have helped deliver protective equipment, medical supplies, and food during this pandemic. McNabb also noted that drones can be used to make complex cleaning processes move quicker, helping businesses with large cleaning needs like stadiums make reopening in a post-pandemic world more possible.

Catch up on previous episodes of Drones In America!

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More